[Dynamics of CK and CK MB activity changes in acute myocardial infarction in patients after fibrinolytic and conventional treatment].
Curyło
A M
AM
I Klinika Kardiologii AM w Krakowie.
Bacior
B
B
Dubiel
J P
JP
Grodecki
J
J
Mroczek-Czernecka
D
D
Kutyba
J
J
D000328:Adult; D000368:Aged; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000201:enzymology*; D005996:Nitroglycerin / Q000627:therapeutic use*; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy
D007527:Isoenzymes; D006493:Heparin; D003402:Creatine Kinase; D013300:Streptokinase; D005996:Nitroglycerin
Dynamika zmian aktywności CK i CK-MB w świezym zawale serca u chorych leczonych fibrynolitycznie i konwencjonalnie.